Portfolio
More coming soon in 2025
Verge Genomics, a leading AI drug discovery company, focuses on aging, neurodegenerative, and autoimmune diseases. With one of the largest proprietary brain tissue biobanks, they’ve identified 160+ new drug targets across 12+ major diseases.
Proprio is a surgical navigation company revolutionizing precision with an AI-powered, light field platform that goes beyond visualization—integrating multi-modal imaging and radiation-free 3D navigation to optimize workflows and elevate surgical capabilities.
Our team’s prior investment highlights
Fountain Life is a precision health company leveraging advanced diagnostics to proactively prevent disease and optimize healthspan.
IPO
4DMT is a gene therapy company with a novel AAV discovery platform.
Oura develops biometric wearables for precision tracking of sleep, autonomic function, and physiological trends
Insilico Medicine is an AI drug discovery platform for longevity and biotech.
Colossal is a de-extinction company developing advanced biotechnologies to revive species and restore ecosystems
Biolinq is a biowearable company developing multi-analyte sensors for real-time metabolic monitoring